These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 21722685

  • 1. Immunization of protein HPV16 E7 in fusion with mouse HSP70 inhibits the growth of TC-1 cells in tumor bearing mice.
    Li YL, Liu J, Liu JN, Zhang J.
    Vaccine; 2011 Aug 11; 29(35):5959-62. PubMed ID: 21722685
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Delta fusion protein vaccine in an animal model.
    Qian X, Lu Y, Liu Q, Chen K, Zhao Q, Song J.
    Immunol Lett; 2006 Feb 15; 102(2):191-201. PubMed ID: 16242781
    [Abstract] [Full Text] [Related]

  • 3. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.
    Mohit E, Bolhassani A, Zahedifard F, Taslimi Y, Rafati S.
    Scand J Immunol; 2012 Jan 15; 75(1):27-37. PubMed ID: 21916914
    [Abstract] [Full Text] [Related]

  • 4. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
    Pokorná D, Macková J, Dusková M, Rittich S, Ludvíková V, Smahel M.
    J Gene Med; 2005 Jun 15; 7(6):696-707. PubMed ID: 15712328
    [Abstract] [Full Text] [Related]

  • 5. Long-term protection against human papillomavirus e7-positive tumor by a single vaccination of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70.
    Zhou L, Zhu T, Ye X, Yang L, Wang B, Liang X, Lu L, Tsao YP, Chen SL, Li J, Xiao X.
    Hum Gene Ther; 2010 Jan 15; 21(1):109-19. PubMed ID: 19715402
    [Abstract] [Full Text] [Related]

  • 6. A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice.
    Granadillo M, Vallespi MG, Batte A, Mendoza O, Soria Y, Lugo VM, Torrens I.
    Vaccine; 2011 Jan 29; 29(5):920-30. PubMed ID: 21145912
    [Abstract] [Full Text] [Related]

  • 7. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors.
    Li YL, Qiu XH, Shen C, Liu JN, Zhang J.
    Oncol Rep; 2010 Nov 29; 24(5):1323-9. PubMed ID: 20878127
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X.
    Int J Mol Med; 2012 Dec 29; 30(6):1335-42. PubMed ID: 23027427
    [Abstract] [Full Text] [Related]

  • 9. Induction of antitumor immunity against cervical cancer by protein HPV-16 E7 in fusion with ricin B chain in tumor-bearing mice.
    Sadraeian M, Rasoul-Amini S, Mansoorkhani MJ, Mohkam M, Ghoshoon MB, Ghasemi Y.
    Int J Gynecol Cancer; 2013 Jun 29; 23(5):809-14. PubMed ID: 23574882
    [Abstract] [Full Text] [Related]

  • 10. Combined E7-dendritic cell-based immunotherapy and human sodium/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer.
    Jeon YH, Lee HW, Lee YL, Kim JE, Hwang MH, Jeong SY, Lee SW, Ahn BC, Ha JH, Lee J.
    Cancer Biother Radiopharm; 2011 Dec 29; 26(6):671-9. PubMed ID: 22091632
    [Abstract] [Full Text] [Related]

  • 11. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
    Tian HW, Ye ZM, Lu ZH, Jao R, Bian T, Zhao L, Ruan L.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun 29; 20(2):33-7. PubMed ID: 16816859
    [Abstract] [Full Text] [Related]

  • 12. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
    Li Y, Subjeck J, Yang G, Repasky E, Wang XY.
    Vaccine; 2006 Jun 19; 24(25):5360-70. PubMed ID: 16714072
    [Abstract] [Full Text] [Related]

  • 13. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
    Lin CT, Yen CF, Shaw SW, Yen TC, Chen YJ, Soong YK, Lai CH.
    Vaccine; 2009 Dec 09; 27(52):7352-8. PubMed ID: 19781679
    [Abstract] [Full Text] [Related]

  • 14. Immunological responses and anti-tumor effects of HPV16/18 L1-L2-E7 multiepitope fusion construct along with curcumin and nanocurcumin in C57BL/6 mouse model.
    Kayyal M, Bolhassani A, Noormohammadi Z, Sadeghizadeh M.
    Life Sci; 2021 Nov 15; 285():119945. PubMed ID: 34516991
    [Abstract] [Full Text] [Related]

  • 15. Enhanced anti-tumor effects of HPV16E7(49-57)-based vaccine by combined immunization with poly(I:C) and oxygen-regulated protein 150.
    Chen S, Ou R, Tang J, Deng X, Wu Y, van Velkinburgh JC, Ni B, Xu Y.
    Cancer Epidemiol; 2013 Apr 15; 37(2):172-8. PubMed ID: 23127963
    [Abstract] [Full Text] [Related]

  • 16. Engineered Salmonella typhimurium expressing E7 fusion protein, derived from human papillomavirus, inhibits tumor growth in cervical tumor-bearing mice.
    Yoon W, Choi JH, Kim S, Park YK.
    Biotechnol Lett; 2014 Feb 15; 36(2):349-56. PubMed ID: 24146199
    [Abstract] [Full Text] [Related]

  • 17. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
    Meshkat Z, Soleimanjahi H, Mirshahabi H, Meshkat M, Kheirandish M, Hassan ZM.
    Iran J Immunol; 2011 Jun 15; 8(2):65-75. PubMed ID: 21705833
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.